Avecho Biotechnology Limited (ASX:AVE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0110
-0.0010 (-8.33%)
Mar 10, 2026, 9:59 AM AEST

Avecho Biotechnology Ratios and Metrics

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
44338112828
Upgrade
Market Cap Growth
131.82%317.27%-28.57%-59.76%0.10%-40.60%
Upgrade
Enterprise Value
3927382423
Upgrade
Last Close Price
0.010.010.000.000.010.01
Upgrade
PS Ratio
35.6126.717.0023.4224.4134.71
Upgrade
PB Ratio
28.2621.202.421.7411.376.07
Upgrade
P/TBV Ratio
28.2621.202.421.7411.496.21
Upgrade
P/FCF Ratio
-29.97----
Upgrade
P/OCF Ratio
39.9629.97----
Upgrade
EV/Sales Ratio
31.8621.962.8517.8121.6928.84
Upgrade
EV/FCF Ratio
-24.64----
Upgrade
Debt / Equity Ratio
0.010.010.330.030.100.02
Upgrade
Debt / FCF Ratio
0.010.01----
Upgrade
Net Debt / Equity Ratio
-2.98-2.98-0.40-0.84-0.50-0.70
Upgrade
Net Debt / EBITDA Ratio
1.221.220.441.640.581.07
Upgrade
Net Debt / FCF Ratio
-4.21-4.210.331.680.710.96
Upgrade
Asset Turnover
0.210.210.180.090.260.19
Upgrade
Inventory Turnover
4.804.803.932.071.121.93
Upgrade
Quick Ratio
9.689.682.707.832.976.31
Upgrade
Current Ratio
9.959.952.818.313.836.91
Upgrade
Return on Equity (ROE)
-182.91%-182.91%-64.72%-78.08%-67.30%-95.01%
Upgrade
Return on Assets (ROA)
-40.85%-40.85%-31.11%-40.10%-33.99%-49.50%
Upgrade
Return on Capital Employed (ROCE)
-61.80%-61.80%-93.30%-52.80%-89.80%-74.90%
Upgrade
Earnings Yield
-10.02%-13.36%-39.40%-30.98%-8.50%-12.40%
Upgrade
FCF Yield
-3.34%-50.09%-28.67%-6.23%-11.99%
Upgrade
Buyback Yield / Dilution
-3.08%-3.08%-39.73%-23.41%-1.97%-13.27%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.